Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 18 |
NetGPI | no | yes: 0, no: 18 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: A4HKG1
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 19 |
GO:0043167 | ion binding | 2 | 19 |
GO:0043169 | cation binding | 3 | 19 |
GO:0046872 | metal ion binding | 4 | 19 |
GO:0003676 | nucleic acid binding | 3 | 2 |
GO:0003723 | RNA binding | 4 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 2 |
GO:1901363 | heterocyclic compound binding | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 12 | 14 | PF00675 | 0.433 |
CLV_NRD_NRD_1 | 73 | 75 | PF00675 | 0.596 |
CLV_PCSK_FUR_1 | 71 | 75 | PF00082 | 0.621 |
CLV_PCSK_KEX2_1 | 12 | 14 | PF00082 | 0.433 |
CLV_PCSK_KEX2_1 | 73 | 75 | PF00082 | 0.596 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.587 |
DEG_SCF_FBW7_2 | 31 | 38 | PF00400 | 0.440 |
DOC_MAPK_gen_1 | 80 | 89 | PF00069 | 0.487 |
DOC_PP4_MxPP_1 | 18 | 21 | PF00568 | 0.716 |
DOC_PP4_MxPP_1 | 59 | 62 | PF00568 | 0.414 |
DOC_USP7_MATH_1 | 104 | 108 | PF00917 | 0.363 |
DOC_USP7_MATH_1 | 119 | 123 | PF00917 | 0.519 |
DOC_USP7_MATH_1 | 62 | 66 | PF00917 | 0.539 |
DOC_USP7_UBL2_3 | 80 | 84 | PF12436 | 0.499 |
DOC_WW_Pin1_4 | 31 | 36 | PF00397 | 0.440 |
LIG_14-3-3_CanoR_1 | 47 | 54 | PF00244 | 0.363 |
LIG_KLC1_Yacidic_2 | 38 | 43 | PF13176 | 0.363 |
LIG_LIR_Apic_2 | 48 | 54 | PF02991 | 0.335 |
LIG_LIR_Apic_2 | 65 | 69 | PF02991 | 0.400 |
LIG_Pex14_1 | 29 | 33 | PF04695 | 0.347 |
LIG_SH2_CRK | 66 | 70 | PF00017 | 0.584 |
LIG_SH2_SRC | 41 | 44 | PF00017 | 0.360 |
LIG_SH2_STAT3 | 57 | 60 | PF00017 | 0.626 |
LIG_SH2_STAT5 | 33 | 36 | PF00017 | 0.397 |
LIG_SH2_STAT5 | 4 | 7 | PF00017 | 0.619 |
LIG_SH2_STAT5 | 41 | 44 | PF00017 | 0.316 |
LIG_SH3_3 | 14 | 20 | PF00018 | 0.593 |
LIG_TRAF2_1 | 106 | 109 | PF00917 | 0.536 |
MOD_CK1_1 | 96 | 102 | PF00069 | 0.357 |
MOD_CK2_1 | 103 | 109 | PF00069 | 0.363 |
MOD_CK2_1 | 24 | 30 | PF00069 | 0.363 |
MOD_GlcNHglycan | 121 | 124 | PF01048 | 0.675 |
MOD_GlcNHglycan | 26 | 29 | PF01048 | 0.253 |
MOD_GSK3_1 | 104 | 111 | PF00069 | 0.534 |
MOD_GSK3_1 | 76 | 83 | PF00069 | 0.582 |
MOD_PKA_2 | 46 | 52 | PF00069 | 0.363 |
MOD_Plk_1 | 55 | 61 | PF00069 | 0.663 |
MOD_ProDKin_1 | 31 | 37 | PF00069 | 0.440 |
TRG_ENDOCYTIC_2 | 15 | 18 | PF00928 | 0.562 |
TRG_ER_diArg_1 | 71 | 74 | PF00400 | 0.610 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P4E5 | Leptomonas seymouri | 46% | 100% |
A0A0N0P975 | Leptomonas seymouri | 80% | 99% |
A0A0S4IT37 | Bodo saltans | 43% | 88% |
A0A1X0NLL7 | Trypanosomatidae | 46% | 97% |
A0A3R7NZE2 | Trypanosoma rangeli | 40% | 88% |
A0A3S7X0B7 | Leishmania donovani | 46% | 84% |
A0A3S7X5L3 | Leishmania donovani | 87% | 98% |
A0A422NH81 | Trypanosoma rangeli | 63% | 73% |
A4HFD2 | Leishmania braziliensis | 43% | 100% |
A4I363 | Leishmania infantum | 46% | 84% |
A4I7Y9 | Leishmania infantum | 87% | 98% |
C9ZKV1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 48% | 98% |
D0AA56 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 64% | 91% |
E9ACZ0 | Leishmania major | 46% | 100% |
E9AYR5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 48% | 100% |
E9B2V0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 98% |
Q4Q5A6 | Leishmania major | 88% | 100% |